By Colin Kellaher
Shares of Kardigan are set to make their trading debut Thursday after the clinical-stage precision therapeutics company's upsized initial public offering was priced at the top of expectations, raising $400 million.
Kardigan late Wednesday said it is selling 25 million shares at $16 apiece in the IPO, compared with prior plans to offer more than 23.3 million shares at between $14 and $16 each.
The pricing gives the Princeton, N.J., company an initial market capitalization of nearly $1.5 billion, assuming the underwriters exercise an option to buy an additional 3.75 million shares.
Kardigan shares are due to begin trading later Thursday on the Nasdaq Global Market under the symbol KARD.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
June 18, 2026 05:54 ET (09:54 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.